Patient samples with low, medium, or high expression of cyclin D3 have high, medium, or low expression of Fbxl8, respectively, underscoring Fbxl8 negatively regulates cyclin D3 expression in human lymphomas in a dose dependent manner. This evidence concerns the gene CCND3 and lymphoma.